Sabine Mueller, Md, Phd
Clinical trials sponsored by Sabine Mueller, Md, Phd, explained in plain language.
-
New hope for kids with devastating brain cancer: first human trial of promising drug begins
Disease control Recruiting nowThis is a first-in-human study to find the safest dose of a new oral drug called ONC206 for children and young adults with aggressive brain tumors, including a type called diffuse midline glioma (DMG). The trial will test the drug alone or in combination with radiation therapy in…
Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Apr 01, 2026 22:11 UTC
-
New hope for kids with rare brain tumors: experimental drug trial now recruiting
Disease control Recruiting nowThis study is testing whether the drug Tovorafenib can help control craniopharyngioma, a rare brain tumor that mostly affects children and young adults. Researchers want to see if the drug can stop tumor growth for at least a year while maintaining patients' physical abilities an…
Phase: PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New immune cell therapy tested in Children's brain tumors
Disease control Recruiting nowThis early-stage study is testing the safety of a new treatment for children and young adults with recurrent or worsening malignant brain tumors. Doctors are injecting specially grown immune cells, called natural killer (NK) cells, directly into the tumor through a small reservoi…
Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC